Axsome’s stock falls after disclosing Teva’s plans to market generic Auvelity

Italia Notizia Notizia

Axsome’s stock falls after disclosing Teva’s plans to market generic Auvelity
Italia Ultime Notizie,Italia Notizie

Shares of Axsome Therapeutics Inc. tumbled about 10.0% in premarket trading on Monday after the company said in a securities filing that Teva Pharmaceutical...

Shares of Axsome Therapeutics Inc.

tumbled about 10.0% in premarket trading on Monday after the company said in a securities filing that Teva Pharmaceutical Industries Ltd. is seeking approval from the Food and Drug Administration to market a generic version of Auvelity, Axsome’s depression treatment. Axsome’s stock has gained 95.8% over the past year, while the S&P 500 SPX declined 7.6%.... Shares of Axsome Therapeutics Inc.

tumbled about 10.0% in premarket trading on Monday after the company said in a securities filing that Teva Pharmaceutical Industries Ltd. is seeking approval from the Food and Drug Administration to market a generic version of Auvelity, Axsome’s depression treatment. Axsome’s stock has gained 95.8% over the past year, while the S&P 500 SPX declined 7.6%.

 

Italia Ultime Notizie, Italia Notizie



Render Time: 2025-01-10 05:22:58